Thomas S Paluck - Net Worth and Insider Trading

Thomas S Paluck Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas S Paluck owns 1 companies in total, including Celldex Therapeutics Inc (CLDX) .

Click here to see the complete history of Thomas S Paluck’s form 4 insider trades.

Insider Ownership Summary of Thomas S Paluck

Ticker	Comapny	Transaction Date	Type of Owner
CLDX	Celldex Therapeutics Inc	2007-01-31	10 percent owner

Thomas S Paluck Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas S Paluck Ownership Network

Ownership Network List of Thomas S Paluck

No Data

Ownership Network Relation of Thomas S Paluck

Thomas S Paluck Owned Company Details

What does Celldex Therapeutics Inc do?

Who are the key executives at Celldex Therapeutics Inc?

Thomas S Paluck is the 10 percent owner of Celldex Therapeutics Inc. Other key executives at Celldex Therapeutics Inc include director & President and CEO Anthony S Marucci , SVP & Chief Product Dev Officer Elizabeth Crowley , and SVP and CFO Samuel Bates Martin .

Celldex Therapeutics Inc (CLDX) Insider Trades Summary

Over the past 18 months, Thomas S Paluck made no insider transaction in Celldex Therapeutics Inc (CLDX). Other recent insider transactions involving Celldex Therapeutics Inc (CLDX) include a net sale of 83,597 shares made by Elizabeth Crowley , a net sale of 97,088 shares made by Margo Heath-chiozzi , and a net sale of 52,172 shares made by Samuel Bates Martin .

In summary, during the past 3 months, insiders sold 0 shares of Celldex Therapeutics Inc (CLDX) in total and bought 11,500 shares, with a net purchase of 11,500 shares. During the past 18 months, 353,560 shares of Celldex Therapeutics Inc (CLDX) were sold and 11,500 shares were bought by its insiders, resulting in a net sale of 342,060 shares.

Celldex Therapeutics Inc (CLDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Celldex Therapeutics Inc Insider Transactions

No Available Data

Thomas S Paluck Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas S Paluck. You might contact Thomas S Paluck via mailing address: 382 Springfield Avenue Suite 500, Summit Nj 07901.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.